Three Korean medical AI and device startups—Raywatt, MedInTech, and Soombit AI—closed a combined $44.7M in funding this week, each tied to specific regulatory or commercial milestones. Meanwhile, Korea's venture investment for the first three quarters of 2026 hit a record 12.6 trillion won, according to the Ministry of SMEs and Startups.
TL;DR
- Three Korean medical AI and device startups raised a combined $44.7M in a single week, each tied to key milestones.
- Korea's venture investment hit a record 12.6 trillion won for the first three quarters of 2026.
- The funding surge reflects growing investor interest in medical AI and the broader startup ecosystem in Korea.
What happened
Cardiovascular imaging startup Raywatt closed a $9.9M Series B round ahead of FDA 510(k) clearance and plans to list on the KOSDAQ in 2028. Medical robotics company MedInTech raised $25.7M in Series C funding to expand its AI robotic endoscope lineup and develop surgical robots. Generative AI medical imaging startup Soombit AI secured $9.1M in Series A funding led by SV Investment and was selected for the Scale-up TIPS program.
Why it matters
The funding rounds highlight the growing interest in medical AI and devices, with each startup at a different stage of development—pre-clearance, scale-up, and early commercialization. This surge in investment reflects the broader trend of increased venture capital activity in Korea, with record funding of 12.6 trillion won for the first three quarters of 2026. The funding channels are also diversifying, with securities firms, banks, technology holding companies, and credit guarantee funds opening new avenues for startup capital.
Key facts
- Raywatt raised $9.9M in Series B funding.
- MedInTech secured $25.7M in Series C funding.
- Soombit AI raised $9.1M in Series A funding.
- Korea's venture investment hit a record 12.6 trillion won for the first three quarters of 2026.
- Raywatt plans to list on the KOSDAQ in 2028.
- Soombit AI was selected for the Scale-up TIPS program.
- The Ministry of Trade, Industry and Energy reported annual exports passed $1 trillion for the first time.
- Ibex secured a 5.24 billion won contract for an F&B autonomous-manufacturing trial.
Context
The record venture investment in Korea underscores the country's growing startup ecosystem and the increasing focus on medical AI and devices. The diversified funding channels, including securities firms, banks, and credit guarantee funds, indicate a maturing investment landscape. The transition of physical AI and AI solutions from lab demos to field deployments and supply deals further highlights the practical applications and commercial potential of these technologies.
